Literature DB >> 23208944

An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.

Ian J Majewski1, Irma Kluijt, Annemieke Cats, Thomas S Scerri, Daphne de Jong, Roelof J C Kluin, Samantha Hansford, Frans B L Hogervorst, Astrid J Bosma, Ingrid Hofland, Marcel Winter, David Huntsman, Jos Jonkers, Melanie Bahlo, René Bernards.   

Abstract

Diffuse gastric cancers typically present as late-stage tumours and, as a result, the 5 year survival rate is poor. Some gastric cancers are hereditary and these tend to be of the diffuse type; 30-40% of hereditary diffuse gastric cancers (HDGCs) can be explained by defective germline alleles of E-cadherin (CDH1), but for the remaining families the factors driving susceptibility remain unknown. We had access to a large HDGC pedigree with no obvious mutation in CDH1, and applied exome sequencing to identify new genes involved in gastric cancer. We identified a germline truncating allele of α-E-catenin (CTNNA1) that was present in two family members with invasive diffuse gastric cancer and four in which intramucosal signet ring cells were detected as part of endoscopic surveillance. The remaining CTNNA1 allele was silenced in the two diffuse gastric cancers from the family that were available for screening, and this was also true for signet ring cells identified in endoscopic biopsies. Since α-E-catenin functions in the same complex as E-cadherin, our results call attention to the broader signalling network surrounding these proteins in HDGC. We also detected somatic mutations in one tumour and found substantial overlap with genes mutated in sporadic gastric cancer, including PIK3CA, ARID1A, MED12 and MED23.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23208944     DOI: 10.1002/path.4152

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  62 in total

1.  Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.

Authors:  Patrick R Benusiglio; Chrystelle Colas; Erell Guillerm; Axelle Canard; Hélène Delhomelle; Mathilde Warcoin; Jérôme Bellanger; Mélanie Eyries; Mohamed Zizi; Jeanne Netter; Florent Soubrier; Yann Parc; Anne Mourregot; Aurélie Maran Gonzalez; Veronica Cusin; Jérôme A Denis; Isabelle Coupier; Magali Svrcek; Florence Coulet
Journal:  Gastric Cancer       Date:  2018-12-04       Impact factor: 7.370

Review 2.  [Gastric tumors and tumor precursors].

Authors:  C Röcken
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

Review 3.  Next generation sequencing-based emerging trends in molecular biology of gastric cancer.

Authors:  Renu Verma; Prakash C Sharma
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

Review 4.  Recognition of and recent issues in hereditary diffuse gastric cancer.

Authors:  Shinya Sugimoto; Hirokazu Komatsu; Yuichi Morohoshi; Takanori Kanai
Journal:  J Gastroenterol       Date:  2015-06-07       Impact factor: 7.527

Review 5.  Resolving gastric cancer aetiology: an update in genetic predisposition.

Authors:  Paul C Lott; Luis G Carvajal-Carmona
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-12

Review 6.  Hereditary diffuse gastric cancer: What the clinician should know.

Authors:  Ryan Ying Cong Tan; Joanne Ngeow
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

7.  Germline mutations in hereditary diffuse gastric cancer.

Authors:  Hao Zhang; Mengmeng Feng; Yi Feng; Zhaode Bu; Ziyu Li; Shuqin Jia; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

Review 8.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

9.  Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival.

Authors:  Cristina Díaz Del Arco; Lourdes Estrada Muñoz; Elena Molina Roldán; Mª Ángeles Cerón Nieto; Luis Ortega Medina; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Virchows Arch       Date:  2018-08-23       Impact factor: 4.064

10.  MicroRNAs in hereditary diffuse gastric cancer.

Authors:  Mayra-Cecilia Suárez-Arriaga; Rosa-María Ribas-Aparicio; Martha-Eugenia Ruiz-Tachiquín
Journal:  Biomed Rep       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.